A systematic review of ultrasound imaging and therapy in mental disorders.

Depressive disorders Flow-mediated dilatation Intima-media thickness Transcranial Doppler Transcranial focused ultrasound Transcranial sonography

Journal

Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617

Informations de publication

Date de publication:
13 07 2020
Historique:
received: 01 11 2019
revised: 06 03 2020
accepted: 09 03 2020
pubmed: 15 3 2020
medline: 5 6 2021
entrez: 15 3 2020
Statut: ppublish

Résumé

Increasing evidence suggests that ultrasound (US) imaging may provide biomarkers and therapeutic options in mental disorders. We systematically reviewed the literature to provide a global overview of the possibilities of US for psychiatry. Original English language articles published between January 2000 and September 2019 were identified through databases searching and analyzed to summarize existing evidence according to PRISMA methodology. A total of 81 articles were included. Various US techniques and markers have been used in mental disorders, including Transcranial Doppler and Intima-Media Thickness. Most of the studies have focused on characterizing the pathophysiology of mental disorders, especially vascular physiology. Studies on therapeutic applications are still scarce. US imaging has proved to be useful in characterizing vascular impairment and structural and functional brain changes in mental disorders. Preliminary findings also suggest potential interests for therapeutic applications. Growing evidence suggests that US imaging could provide a non-invasive, portable and low-cost tool for pathophysiological characterization, prognostic assessment and therapeutic applications in mental disorders.

Sections du résumé

BACKGROUND
Increasing evidence suggests that ultrasound (US) imaging may provide biomarkers and therapeutic options in mental disorders. We systematically reviewed the literature to provide a global overview of the possibilities of US for psychiatry.
METHODS
Original English language articles published between January 2000 and September 2019 were identified through databases searching and analyzed to summarize existing evidence according to PRISMA methodology.
RESULTS
A total of 81 articles were included. Various US techniques and markers have been used in mental disorders, including Transcranial Doppler and Intima-Media Thickness. Most of the studies have focused on characterizing the pathophysiology of mental disorders, especially vascular physiology. Studies on therapeutic applications are still scarce.
DISCUSSION
US imaging has proved to be useful in characterizing vascular impairment and structural and functional brain changes in mental disorders. Preliminary findings also suggest potential interests for therapeutic applications. Growing evidence suggests that US imaging could provide a non-invasive, portable and low-cost tool for pathophysiological characterization, prognostic assessment and therapeutic applications in mental disorders.

Identifiants

pubmed: 32169563
pii: S0278-5846(19)30918-2
doi: 10.1016/j.pnpbp.2020.109919
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

109919

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest WEH reports personal fees from EISAI, Japan, Janssen, USA, Lundbeck, Denmark, Otsuka, Japan, UCB, Belgium, Roche, Switzerland and Chugai, Japan. He received grants from the Fondation de France, France, and from the French National Hospital Program for Clinical Research (PHRC), unrelated to the submitted work. TD reports personal fees from Janssen, Lundbeck, Otsuka and Eisai. He received grants from the Fondation de l'Avenir, France, and from the French National Hospital Program for Clinical Research (PHRC), France, unrelated to the submitted work. All other authors declare no competing interests.

Auteurs

Marta Andrea Siragusa (MA)

UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.

Jean-Pierre Réméniéras (JP)

UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.

Ayache Bouakaz (A)

UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.

Jean-Michel Escoffre (JM)

UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.

Frédéric Patat (F)

UMR 1253, iBrain, Université de Tours, Inserm, Tours, France; CHU de Tours, Tours, France; CIC 1415, CHU Tours, Inserm, Tours Cedex, France.

Paul-Armand Dujardin (PA)

CIC 1415, CHU Tours, Inserm, Tours Cedex, France.

Bruno Brizard (B)

UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.

Catherine Belzung (C)

UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.

Vincent Camus (V)

UMR 1253, iBrain, Université de Tours, Inserm, Tours, France; CHU de Tours, Tours, France.

Wissam El-Hage (W)

UMR 1253, iBrain, Université de Tours, Inserm, Tours, France; CHU de Tours, Tours, France; CIC 1415, CHU Tours, Inserm, Tours Cedex, France.

Thomas Desmidt (T)

UMR 1253, iBrain, Université de Tours, Inserm, Tours, France; CHU de Tours, Tours, France. Electronic address: t.desmidt@chu-tours.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH